Global Early Phase Clinical Trial Outsourcings Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Early Phase Clinical Trial Outsourcings Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

There are 3 main phases of clinical trials – phases 1 to 3. But trials have an earlier stage called phase 1,Phase 1 trials are usually the earliest trials of drugs in people. But your doctor might ask if you would like to join a phase 1 study. Phase 1 studies usually only involve a small number of people and they only have a very small dose of a drug. The dose of the drug is too small to treat your cancer,

Market Overview:

The latest research study on the global Early Phase Clinical Trial Outsourcings market finds that the global Early Phase Clinical Trial Outsourcings market reached a value of USD 8587.35 million in 2022. It’s expected that the market will achieve USD 11560.59 million by 2028, exhibiting a CAGR of 5.08% during the forecast period.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

IQVIA is one of the major players operating in the Early Phase Clinical Trial Outsourcings market, holding a share of 15.48% in 2018.

IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical.

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services.

Segmentation Overview:

By type, Clinical Data Management (CDM) segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Pharmaceutical Companies segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Early Phase Clinical Trial Outsourcings market covered in Chapter 3:

IQVIA
Covance
SGS life Science
Sofpromed
PAREXEL International Corporation
PPD
Quanticate
PRA Health Sciences
Syneos Health
Chiltern International Ltd
ICON Plc
Charles River Laboratories

In Chapter 4 and Chapter 14.2, on the basis of types, the Early Phase Clinical Trial Outsourcings market from 2018 to 2029 is primarily split into:

Regulatory Services
Clinical Data Management (CDM)
Medical Writing
Site Management
Pharmacovigilance (PV)
Risk-Based Monitoring
Bio Statistical Services
Protocol Development
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Early Phase Clinical Trial Outsourcings market from 2018 to 2029 covers:

Pharmaceutical Companies
Biopharmaceutical Companies
Drug Discovery Companies
Medical Devices Companies
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)